title: Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.
authors.forename: Silvia
authors.initials: S
authors.lastname: Mangiacavalli
authors.forename: Gianmatteo
authors.initials: G
authors.lastname: Pica
authors.forename: Marzia
authors.initials: M
authors.lastname: Varettoni
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
authors.forename: Alessandro
authors.initials: A
authors.lastname: Corso
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000009:adverse effects* / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000009:adverse effects* / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; C054368:fotemustine